A phase I clinical trial of a multi-epitope polypeptide TAB9 combined with Montanide ISA 720 adjuvant in non-HIV-1 infected human volunteers

Prevention of HIV-1 infection in chimpanzees by gpl20 V3 domain-specific monoclonal antibody

Emilio A. Emini, William A. Schleif, Jack H. Nunberg et al. · Nature · 1992 · 476 citations

Life Sciences, Immunology, Infectious Diseases +14

Immunization with Envelope Subunit Vaccine Products Elicits Neutralizing Antibodies against Laboratory-Adapted but Not Primary Isolates of Human Immunodeficiency Virus Type 1

John R. Mascola, S W Snyder, O. S. Weislow et al. · The Journal of Infectious Diseases · 1996 · 434 citations

Life Sciences, Immunology, Microbiology +10

Immunization of chimpanzees confers protection against challenge with human immunodeficiency virus.

Marc Girard, M. P. Kieny, Abraham Pinter et al. · Proceedings of the National Academy of Sciences · 1991 · 353 citations

Life Sciences, Immunology, Infectious Diseases +14

Interleukin-2 production used to detect antigenic peptide recognition by T-helper lymphocytes from asymptomatic HIV-seropositive individuals

Mario Clerici, N I Stocks, R A Zajac et al. · Nature · 1989 · 219 citations

Life Sciences, Immunology, Infectious Diseases +17

The Safety and Immunogenicity of a Human Immunodeficiency Virus Type 1 (HIV-1) Recombinant gp160 Candidate Vaccine in Humans

Raphael Dolin, Barney S. Graham, Stephen B. Greenberg et al. · Annals of Internal Medicine · 1991 · 169 citations

Veterinary Medicine, Immunology, Infectious Diseases +17